Recruiting
Sleep Promotion and Pediatric Hypertension
Determine the effectiveness and feasibility of a mobile health sleep extension approach in the pediatric nephrology setting, to increase sleep duration and reduce systolic and diastolic blood pressure.
ClinicalTrials.gov IDNCT06642246
PhaseNA
Enrollment10
SponsorChildren's Hospital of Philadelphia
Age13 Years
SexALL
Conditions studied
Insufficient Sleep, Hypertension
About this study
Determine the effectiveness and feasibility of a mobile health sleep extension approach in the pediatric nephrology setting, to increase sleep duration and reduce systolic and diastolic blood pressure.
Interventions
- Behavioral: Intervention — During a 7-week intervention phase, parent-child dyads will be provided a sleep duration goal paired with a loss-framed financial incentive (virtual account) starting with deductions each time the sleep goal is not met, will be sent sleep guidance text messages, and will receive weekly performance feedback text messages.
Primary outcomes
- Hypertension (From baseline to approximately week 11)
- Change in sleep tracker estimated weeknight sleep duration (From baseline to approximately week 11)
Eligibility information
Inclusion Criteria:
* Speak, read and write in English.
* Parental/guardian permission (informed consent) and child assent.
* Have a computer or a tablet computer with access to the Internet or own a smartphone with a data and text plan.
* Parent reported sleep duration on school nights less than or equal to 7.5 hours.
* Recently diagnosed with essential hypertension by Ambulatory Blood Pressure Monitoring (ABPM).
* If taking over the counter sleep aides, willing to stop them over the course of the study.
Exclusion Criteria:
* Any clinically diagnosed sleep disorder (e.g. sleep apnea) in the electronic health record and or regular use of prescribed sleep aide.
* Underlying chronic medical conditions, defined as a medical condition with a duration or expected duration longer than 3 months that involved taking regular medication, taking medications that could affect blood pressure (e.g., anti-hypertensive medications, glucocorticoids, or stimulants), and patients with underlying diagnoses known to be associated with elevated blood pressure (e.g., cardiac disease, kidney disease or diabetes).
Inclusion Criteria for Parents/Legal Guardians:
* Be the parent/guardian of an eligible child enrolled in the main study.
* Speak, read, and write in English.
Exclusion Criteria for Parents/Legal Guardians:
\- Limited English proficiency
Study locations
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19146 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.